Can Wuhan Rich Bioengineering Co., Ltd. produce COVID-19 antigen?

Yes, in order to further expand the production capacity of epidemic prevention medical devices, the US Food and Drug Administration actively sought the support of the State Administration of Medical Supplies, and successfully registered the antigen detection reagent of Biotech (Wuhan) Co., Ltd. for emergency approval. In less than a week, the company got the registration certificate of antigen detection reagent. After that, several offices of the provincial US Food and Drug Administration cooperated and went through the production license procedures for the company on the same day. The Provincial Food and Drug Administration has opened a special channel for the production enterprises of epidemic prevention medical machinery that need to expand their production capacity, initiated the emergency review and approval mechanism, and successively handled the entrusted production procedures for Zhen 'ao Honeysuckle Pharmaceutical Co., Ltd., and increased the production address procedures for Wuhan Shengzhiyuan Biotechnology Co., Ltd. and Wuhan Ruiqi Biotechnology Co., Ltd., with an average time of less than 1 working day.